Atrial septal defect indications for surgical repair in adults: Difference between revisions

Jump to navigation Jump to search
Line 10: Line 10:
'''1)''' '''Amount of blood shunting across the defect'''
'''1)''' '''Amount of blood shunting across the defect'''


* Size and amount of [[left-to-right shunt]]ing across the defect serve as a good indicator of the progression and worsening of the disease. The pulmonary-to-systemic flow ratio Qp/Qs gives a good idea of the shunting.  
'''1''' Size and amount of [[left-to-right shunt]]ing across the defect serve as a good indicator of the progression and worsening of the disease.


* [[Cardiac catheterization]] gives more accurate diagnosis of Qp/Qs, however [[echocardiography]] and [[doppler ultrasound]] is more commonly used as they are convenient, non-invasive and cheap.
'''2''' The pulmonary-to-systemic flow ratio Qp/Qs gives a good idea of the shunting.  


* Qp/Qs is calculated as  Qp/Qs = [PA diameter(2) x VTI-PA] ÷ [LVOT diameter(2) x VTI-LVOT] where PA = [[pulmonary artery]], VTI-PA = velocity time of the [[Doppler flow]] signal, LVOT = [[left ventricular outflow tract]], and VIT-LVOT = maximum Doppler flow velocity apical to the [[aortic valve]].
'''3''' [[Cardiac catheterization]] gives most accurate diagnosis of Qp/Qs


* In case the [[pulmonary arterial pressure]] is more than 2/3rd of the [[systemic systolic pressure]], it could cause a net [[left-to-right shunt]] of at least 1.5:1 or evidence of reversibility of the shunt when given [[pulmonary artery]] [[vasodilators]] prior to surgery. If [[Eisenmenger's syndrome]] has developed, it must be demonstrated that the right-to-left shunt is reversible with [[pulmonary artery]] [[vasodilators]] prior to surgery.
'''4''' [[Echocardiography]] and [[doppler ultrasound]] are more commonly used as they are convenient, non-invasive and cheap.


* The [[American Heart Association]] has recommended a threshold '''Qp/Qs ≥1.5:1''' for patients '''21''' years of age or older. <ref name="pmid7923709">{{cite journal| author=Driscoll D, Allen HD, Atkins DL, Brenner J, Dunnigan A, Franklin W et al.| title=Guidelines for evaluation and management of common congenital cardiac problems in infants, children, and adolescents. A statement for healthcare professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, American Heart Association. | journal=Circulation | year= 1994 | volume= 90 | issue= 4 | pages= 2180-8 | pmid=7923709 | doi= | pmc= | url= }} </ref>
'''5''' Qp/Qs is calculated as  Qp/Qs = [PA diameter(2) x VTI-PA] ÷ [LVOT diameter(2) x VTI-LVOT] where


* The Canadian Cardiac Society recommended a threshold '''Qp/Qs >2:1, or >1.5:1''' in the presence of reversible [[pulmonary hypertension]] <ref name="pmid11586386">{{cite journal| author=Therrien J, Dore A, Gersony W, Iserin L, Liberthson R, Meijboom F et al.| title=CCS Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Part I. | journal=Can J Cardiol | year= 2001 | volume= 17 | issue= 9 | pages= 940-59 | pmid=11586386 | doi= | pmc= | url= }} </ref>.  
* PA = [[pulmonary artery]],
* VTI-PA = velocity time of the [[Doppler flow]] signal
* LVOT = [[left ventricular outflow tract]]
* VIT-LVOT = maximum Doppler flow velocity apical to the [[aortic valve]].


* The Qp/Qs ratio can change as the disease progresses. Due to this it has been recommended to have a [[echocardiography]] every 2-3 years in asymptomatic patients.  
'''6''' In case the [[pulmonary arterial pressure]] is more than 2/3rd of the [[systemic systolic pressure]], it could cause a net [[left-to-right shunt]] of at least 1.5:1 or evidence of reversibility of the shunt when given [[pulmonary artery]] [[vasodilators]] prior to surgery.
 
'''7''' If [[Eisenmenger's syndrome]] has developed, it must be demonstrated that the right-to-left shunt is reversible with [[pulmonary artery]] [[vasodilators]] prior to surgery.
 
'''8''' The [[American Heart Association]] has recommended a threshold '''Qp/Qs ≥1.5:1''' for patients '''21''' years of age or older. <ref name="pmid7923709">{{cite journal| author=Driscoll D, Allen HD, Atkins DL, Brenner J, Dunnigan A, Franklin W et al.| title=Guidelines for evaluation and management of common congenital cardiac problems in infants, children, and adolescents. A statement for healthcare professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, American Heart Association. | journal=Circulation | year= 1994 | volume= 90 | issue= 4 | pages= 2180-8 | pmid=7923709 | doi= | pmc= | url= }} </ref>
 
'''9''' The Canadian Cardiac Society recommended a threshold '''Qp/Qs >2:1, or >1.5:1''' in the presence of reversible [[pulmonary hypertension]] <ref name="pmid11586386">{{cite journal| author=Therrien J, Dore A, Gersony W, Iserin L, Liberthson R, Meijboom F et al.| title=CCS Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Part I. | journal=Can J Cardiol | year= 2001 | volume= 17 | issue= 9 | pages= 940-59 | pmid=11586386 | doi= | pmc= | url= }} </ref>.
 
'''10''' The Qp/Qs ratio can change as the disease progresses. Due to this it has been recommended to have a [[echocardiography]] every 2-3 years in asymptomatic patients.  


'''2)''' '''Development of symptoms'''
'''2)''' '''Development of symptoms'''

Revision as of 01:05, 11 September 2011

Atrial Septal Defect Microchapters

Home

Patient Information

Overview

Anatomy

Classification

Ostium Secundum Atrial Septal Defect
Ostium Primum Atrial Septal Defect
Sinus Venosus Atrial Septal Defect
Coronary Sinus
Patent Foramen Ovale
Common or Single Atrium

Pathophysiology

Epidemiology and Demographics

Risk Factors

Natural History and Prognosis

Complications

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Transesophageal Echocardiography
Transthoracic Echocardiography
Contrast Echocardiography
M-Mode
Doppler

Transcranial Doppler Ultrasound

Cardiac Catheterization

Exercise Testing

ACC/AHA Guidelines for Evaluation of Unoperated Patients

Treatment

Medical Therapy

Surgery

Indications for Surgical Repair
Surgical Closure
Minimally Invasive Repair


Robotic ASD Repair
Percutaneous Closure
Post-Surgical Follow Up

Special Scenarios

Pregnancy
Diving and Decompression Sickness
Paradoxical Emboli
Pulmonary Hypertension
Eisenmenger's Syndrome
Atmospheric Pressure

Case Studies

Case #1

Atrial septal defect indications for surgical repair in adults On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atrial septal defect indications for surgical repair in adults

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrial septal defect indications for surgical repair in adults

CDC on Atrial septal defect indications for surgical repair in adults

Atrial septal defect indications for surgical repair in adults in the news

Blogs on Atrial septal defect indications for surgical repair in adults

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Atrial septal defect indications for surgical repair in adults

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3] Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]

Overview

The decision for surgical closure in atrial septal defects depends on many contributing factors like type of defect, size of defect, amount of left-to-right shunting, development or worsening of symptoms, presence of pulmonary hypertension and presence of any associated anomalies.

Indications for atrial septal defect closure

1) Amount of blood shunting across the defect

1 Size and amount of left-to-right shunting across the defect serve as a good indicator of the progression and worsening of the disease.

2 The pulmonary-to-systemic flow ratio Qp/Qs gives a good idea of the shunting.

3 Cardiac catheterization gives most accurate diagnosis of Qp/Qs

4 Echocardiography and doppler ultrasound are more commonly used as they are convenient, non-invasive and cheap.

5 Qp/Qs is calculated as Qp/Qs = [PA diameter(2) x VTI-PA] ÷ [LVOT diameter(2) x VTI-LVOT] where

6 In case the pulmonary arterial pressure is more than 2/3rd of the systemic systolic pressure, it could cause a net left-to-right shunt of at least 1.5:1 or evidence of reversibility of the shunt when given pulmonary artery vasodilators prior to surgery.

7 If Eisenmenger's syndrome has developed, it must be demonstrated that the right-to-left shunt is reversible with pulmonary artery vasodilators prior to surgery.

8 The American Heart Association has recommended a threshold Qp/Qs ≥1.5:1 for patients 21 years of age or older. [1]

9 The Canadian Cardiac Society recommended a threshold Qp/Qs >2:1, or >1.5:1 in the presence of reversible pulmonary hypertension [2].

10 The Qp/Qs ratio can change as the disease progresses. Due to this it has been recommended to have a echocardiography every 2-3 years in asymptomatic patients.

2) Development of symptoms

  • Development and worsening of symptoms such as shortness of breath, exercise intolerance, fatigue, swelling of feet and ankle or abdomen (suggesting right sided heart failure), recurrent respiratory infections along with echocardiographic abnormalities are an indication for repair.
  • Arrrhythmias as an isolated symptom can occur in 1 out of 5 adults patients with atrial septal defects. The surgical closure for patients presenting only with arrhythmia is controversial as not much benefit could be derived even after surgery.

3) Size of defect

  • Secundum ASDs <6 mm diameter in infants may close spontaneously by the end of two years of life. Thus, in asymptomatic patients with small defects early closure is not indicated.
  • Defects of moderate size (6 to 8 mm) have fewer chances to close spontaneously. Despite this surgical closure of these defects are not indicated before two years of age, in case these are asymptomatic

4) Age

  • Closure of an ASD in individuals under age 25 has been shown to have a low risk of complications, and individuals have a normal lifespan (comparable to a healthy age-matched population).
  • Closure of an ASD in individuals between the ages of 25 and 40 who are asymptomatic but have a clinically significant shunt is controversial. Those that perform the procedure believe that they are preventing long-term deterioration in cardiac function and preventing progression of pulmonary hypertension.

Trial supportive data

In a study done by Konstantinides et al. it was found that the surgical repair of an atrial septal defect in patients over 40 years of age, decreases all causes mortality, increases long-term survival and decreases complications like heart failure when compared with medical therapy. However, surgically treated patients may have an increased risk of arrhythmias and thromboembolic episodes and therefore should be closely watched for it.[3]

Special conditions

Pulmonary hypertension

Eisenmenger's syndrome

Pregnancy

Migraine

References

  1. Driscoll D, Allen HD, Atkins DL, Brenner J, Dunnigan A, Franklin W; et al. (1994). "Guidelines for evaluation and management of common congenital cardiac problems in infants, children, and adolescents. A statement for healthcare professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, American Heart Association". Circulation. 90 (4): 2180–8. PMID 7923709.
  2. Therrien J, Dore A, Gersony W, Iserin L, Liberthson R, Meijboom F; et al. (2001). "CCS Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Part I.". Can J Cardiol. 17 (9): 940–59. PMID 11586386.
  3. Konstantinides S, Geibel A, Olschewski M, Görnandt L, Roskamm H, Spillner G; et al. (1995). "A comparison of surgical and medical therapy for atrial septal defect in adults". N Engl J Med. 333 (8): 469–73. doi:10.1056/NEJM199508243330801. PMID 7623878.

See also


Template:WikiDoc Sources